Globe Newswire
Globe Newswire
More Globe Newswire
View Older Stories View Newer Stories-
ZyVersa Therapeutics Highlights Data Demonstrating a Critical Need for Therapies to Address Kidney Lipotoxicity to Alleviate Diabetic Kidney Disease (DKD) and Its Progression
-
OneMedNet Reports 80% Reduction in Debt Enabling Focus On Growth
-
CoreCard Corporation Reports Second Quarter 2025 Results
-
Avicanna Reports Q2 2025
-
FirstCash Completes Acquisition of H&T Group; Combination Establishes FirstCash as U.K.’s Leading Pawnbroker; Now Operates over 3,300 Retail Pawn Locations in the U.S., Latin America and the U.K.
-
FirstCash Completes Acquisition of H&T Group; Combination Establishes FirstCash as U.K.’s Leading Pawnbroker; Now Operates over 3,300 Retail Pawn Locations in the U.S., Latin America and the U
-
Advanced Flower Capital Inc. Announces Financial Results for the Second Quarter 2025
-
Festi hf.: Managers and persons´ closely associated transactions
-
First American Uranium Announces Non-Brokered Private Placement of Shares
-
Edible Garden Delivers Strong Performance Across Core and Key Segments, Driven by Strategic Portfolio Transformation
-
Evaxion announces business update and second quarter 2025 financial results
-
Lexeo Therapeutics Reports Second Quarter 2025 Financial Results and Operational Highlights
-
nCino Announces Timing of its Second Quarter Fiscal Year 2026 Financial Results Conference Call
-
Gaming and Leisure Properties Announces Pricing of $600,000,000 of 5.250% Senior Notes Due 2033 and $700,000,000 of 5.750% Senior Notes Due 2037
-
Palvella Therapeutics Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
Xtract One Drives International Growth Through US$2.6 Million Follow-On Contract with Global Entertainment Organization
-
Plus Therapeutics Presents Positive CNSide CSF Assay Platform Results at the 2025 SNO/ASCO CNS Metastases Conference
-
FUNDAMENTAL GLOBAL INC. STRENGTHENS BOARD OF DIRECTORS WITH APPOINTMENT OF BLOCKCHAIN PIONEER MAJA VUJINOVIC AND SUCESSFUL SERIAL ENTERPRENEUR & VENTURE CAPITALIST JOSE VARGAS
-
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
-
MediPharm Strengthens Global Position in Q2 2025, with 14% Revenue Growth and 50% Increase in International Medical Cannabis
-
FUNDAMENTAL GLOBAL INC. STRENGTHENS BOARD OF DIRECTORS WITH APPOINTMENT OF BLOCKCHAIN PIONEER MAJA VUJINOVIC AND SUCESSFUL SERIAL ENTERPRENEUR & VENTURE CAPITALIST JOSE VARGAS
-
3 E Network Announces Strategic Intent to Seize Opportunities in the New Compliance-Driven Stablecoin Era
-
LM Funding America, Inc. Reports Second Quarter 2025 Financial Results
-
MiNK Therapeutics Reports Clinical and Strategic Milestones and Second Quarter 2025 Results
-
NeuroOne® Reports Third Quarter Fiscal Year 2025 Financial Results; Revenue Increases 105% YoY and Gross Margin Expands to 53.9%
-
Cannara Biotech Enhances Financial Flexibility Through Strategic Asset Sale
-
KOIL Energy Reports Second Quarter 2025 Results and Provides a Business Update
-
Xilio Therapeutics Announces Pipeline and Business Updates and Second Quarter 2025 Financial Results
-
Abeona Therapeutics® Reports Second Quarter 2025 Financial Results and Corporate Updates
-
Cassava Reports Q2 2025 Financials Results and Provides Business Update
-
nCino Announces Timing of its Second Quarter Fiscal Year 2026 Financial Results Conference Call
-
Jonathan Low Named Forbes 40 Under 40 for Tech Innovation and Global Finance Impact
-
DogWalker Announces DOGWALK Token Pre-Sale, Transforming Blockchain Pet Care
-
IREN to Release FY25 Results on August 28, 2025
-
Cellectar Biosciences Reports Second Quarter 2025 Financial Results and Provides a Corporate Update
-
Newton Golf Company Reports Second Quarter 2025 Financial Results
-
FLSmidth updates its financial guidance for 2025: Adjusted EBITA margin guidance upgraded, while revenue guidance lowered
-
reAlpha Tech Corp. Announces 1,909% Year-over-Year Revenue Growth for Quarter Ended June 30, 2025
-
TeraWulf Secures Long-Term Ground Lease at Cayuga Site to Expand High-Performance Computing Infrastructure
-
CRB Expands Life Sciences Leadership Team with Appointment of Senior Director Eric Hanson
-
Chicago Atlantic BDC, Inc. Declares $0.34 Cash Dividend for Third Quarter 2025
-
EvolveImmune Therapeutics Announces FDA Clearance of Investigational New Drug Application for EVOLVE104, a Novel Trispecific T Cell Engager with Integrated CD2 Costimulation
-
Evoke Pharma Reports Second Quarter 2025 Financial Results and Provides Business Update
-
Predictive Oncology Reports Second Quarter 2025 Financial Results and Provides Corporate Update
-
AMG Appoints Marcy Engel to its Board of Directors
-
Unicycive Therapeutics Announces Second Quarter 2025 Financial Results and Provides Business Update
-
Asante Announces Receipt of Net Proceeds from $125M Mezzanine, $50M Stream, $10M Non-Brokered Private Placement Financings, $5M Senior Debt First Utilization
-
SEED Therapeutics Named Finalist for 2025 Prix Galien USA “Best Start-Up” Award
-
Lungpacer Announces CMS NTAP Approval for AeroPace® System in FY2026 IPPS Final Rule
-
Infinity Loop Raises $5M; Empowers Enterprises to Save Millions on Vendor Contracts
